Study details first therapeutic melanoma vaccine

submitted by: mdanderson
Scientists, led by Patrick Hwu, M.D., of MD Anderson Cancer Center, and Douglas Schwartzentruber, M.D., of Goshen Center for Cancer Care, have developed a vaccine for advanced melanoma. When combined with Interleuken-2, the cocktail stimulates the body's immune system to recognize and ultimately fight cancer cells. Drs. Hwu and Schwartzentruber explain their findings, which are published in the New England Journal of Medicine, and discuss other recent advances in the treatment and research...

Treatment Could Provide Relief for Leukemia Patients

submitted by: mdanderson
At least 40% of leukemia patients seen at MD Anderson Cancer Center in Houston, experience pneumonia in their initial treatments. Scott Evans, M.D., assistant professor in Pulmonary Medicine, Evans and his colleagues have identified a combination of two small molecules that stimulate the lungs to become resistant to infection. They're goal is to use this combination to prevent pneumonia in patients with acute leukemia. Evans describes the research that's being done. http://bit.ly/iMGN4b

Lymphedema: Basics, Management and New Research

submitted by: mdanderson
http://bit.ly/CancerNL Many women and men develop lymphedema following cancer surgery. Its onset can occur as far out as two--five years later. Kathleen Smalky, M.D., associate professor in the Department of General Internal Medicine at MD Anderson Cancer Center, explains how lymphedema occurs, why self-care is important, and discusses what research is being conducted to help those who have this common condition.